Submission to Health Canada - Agile Licensing for Drugs

The Canadian Life and Health Insurance Association (CLHIA) is pleased to provide the views of its members to Health Canada for consideration regarding the consultation on Agile Licensing for
Drugs, which proposes to make changes to drug review processes that reduce regulatory issues and roadblocks to innovation while making Canada’s regulatory system more agile and internationally aligned.

HC - Agile Licensing for Drugs Final.pdf